Author： Boules Mona
Publisher： Adis International
ISSN： 1172-7047
Source： CNS Drugs, Vol.21, Iss.1, 2007-01, pp. : 13-23
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Neurotensin (NT) is a neuropeptide that, for decades, has been implicated in the biology of schizophrenia. It is closely associated with, and is thought to modulate, dopaminergic and other neurotransmitter systems involved in the pathophysiology of various neuropsychiatric diseases, including schizophrenia.This review outlines the neurochemistry and function of the NT system and the data implicating its role in schizophrenia. The data suggest that NT receptor agonists have the potential to be used as novel therapeutic agents for the treatment of schizophrenia, with the added benefits of (i) not causing weight gain, an adverse effect that is problematic with some of the currently used atypical antipsychotic drugs; and (ii) helping patients to stop smoking, a behaviour that is highly prevalent in those with schizophrenia.
Related content
Access to resources
Recommend
Galantamine is of potential benefit in the treatment of schizophrenia
Inpharma, Vol. 1, Iss. 1354, 2002-01 ,pp. :